Castleark Management LLC Castle Biosciences Inc Transaction History

Castleark Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$39.06 - $67.58 $5.78 Million - $9.99 Million	-147,867 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $455,184 - $587,432	-7,570 Reduced 4.87%	147,867 $9.83 Million
Q2 2021 Aug 17, 2021	SELL	$50.07 - $76.78 $409,071 - $627,292	-8,170 Reduced 4.99%	155,437 $11.4 Million
Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $907,957 - $1.5 Million	15,410 Added 10.4%	163,607 $11.2 Million
Q4 2020 Feb 17, 2021	SELL	$43.6 - $73.05 $736,883 - $1.23 Million	-16,901 Reduced 10.24%	148,197 $9.95 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $668,339 - $903,917	17,373 Added 11.76%	165,098 $8.49 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $4.03 Million - $6.35 Million	147,725 New	147,725 $5.57 Million

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $750M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.